Gardasil : fast-tracked and flawed /
Saved in:
Author / Creator: | Lobato, Helen, author. |
---|---|
Imprint: | North Geelong, Vic. : Spinifex Press, 2017. |
Description: | 1 online resource |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11676963 |
ISBN: | 9781742199948 1742199941 9781742199962 1742199968 9781742199955 174219995X |
---|---|
Notes: | Includes bibliographical references. |
Summary: | The author argues that there is no evidence of how much cervical cancer HPV vaccine will prevent. What is emerging, however, is evidence of its harmful effects. In the nine years since the experimental HPV vaccination program began, there have been 255 associated deaths worldwide and 43,000 adverse events. Gardasil was fast-tracked through the FDA, a process usually reserved for serious diseases where a new drug required to fill an unmet and urgent medial need. Yet the incidence of cervical cancer had already been markedly in decline due to Pap smear programs. This in-depth investigation of the approval of a vaccine exposes cracks in the pharmaceutical industry and highlights the problems that arise when government regulators and corporate interests are prioritised ahead of patient safety and independent science. |
Similar Items
-
Not quite a cancer vaccine : selling HPV and cervical cancer /
by: Gottlieb, S. D. (Samantha D.)
Published: (2018) -
Not quite a cancer vaccine : selling HPV and cervical cancer /
by: Gottlieb, S. D. (Samantha D.)
Published: (2018) -
Vaccines for the prevention of cervical cancer /
Published: (2008) -
Screening for cancer of the uterine cervix : from the IARC Working Group on Cervical Cancer Screening and the UICC Project Group on the Evaluation of Screening Programmes for Cancer /
Published: (1986) -
Cervical cancer : from etiology to prevention /
Published: (2004)